Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 119 |  VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 503.39 USD | -0.44% | -0.66% | -3.93% | +20.05% | 127.59 B USD | ||
| 211 |  MRNA Moderna, Inc. - Common Stock | 197.20 USD | +0.37% | +4.38% | +40.56% | +603.78% | 78.73 B USD | ||
| 218 |  REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 739.50 USD | -0.35% | +0.64% | -8.00% | +29.96% | 76.14 B USD | ||
| 306 |  ARGX argenx SE - American Depositary Shares | 817.80 USD | -11.92% | -12.63% | -17.53% | +2.67% | 50.61 B USD | ||
| 369 |  RVMD Revolution Medicines, Inc. - Common Stock | 188.10 USD | -6.36% | -8.64% | -8.69% | +239.53% | 40.32 B USD | ||
| 446 |  ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 224.53 USD | +0.05% | -2.82% | -12.46% | -50.22% | 30.04 B USD | ||
| 506 |  RPRX Royalty Pharma plc - Class A Ordinary Shares | 56.21 USD | -0.97% | -2.46% | -7.24% | +50.86% | 25.10 B USD | ||
| 512 |  ROIV Roivant Sciences Ltd. - Common Shares | 34.23 USD | -1.50% | -3.58% | -17.30% | +86.95% | 24.73 B USD | ||
| 530 |  INCY Incyte Corporation - Common Stock | 112.73 USD | -0.63% | -3.76% | -9.38% | +31.77% | 22.85 B USD | ||
| 531 |  UTHR United Therapeutics Corporation - Common Stock | 532.78 USD | -2.24% | -6.76% | +6.99% | +18.44% | 22.85 B USD | ||
| 539 |  BNTX BioNTech SE - American Depositary Shares | 92.06 USD | -3.35% | -4.89% | -6.54% | -13.34% | 22.09 B USD | ||
| 551 |  INSM Insmed Incorporated - Common Stock | 100.61 USD | -1.11% | -7.29% | -18.86% | -37.91% | 21.97 B USD | ||
| 684 |  EXEL Exelixis, Inc. - Common Stock | 59.02 USD | +0.99% | +1.86% | +2.64% | +51.18% | 14.62 B USD | ||
| 700 |  JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 222.45 USD | -3.78% | -4.53% | -6.70% | +58.89% | 14.44 B USD | ||
| 711 |  ASND Ascendis Pharma A/S - American Depositary Shares | 222.63 USD | -2.53% | -1.93% | -17.15% | +8.56% | 13.80 B USD | ||
| 723 |  SMMT Summit Therapeutics Inc. - Common Stock | 17.18 USD | -4.29% | +3.00% | -5.29% | -13.49% | 13.71 B USD | ||
| 752 |  CORT Corcept Therapeutics Incorporated - Common Stock | 118.54 USD | -0.89% | +3.96% | +3.80% | +61.56% | 12.81 B USD | ||
| 766 |  BBIO BridgeBio Pharma, Inc. - Common Stock | 65.04 USD | -2.20% | -2.79% | -11.67% | +14.11% | 12.71 B USD | ||
| 778 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 109.86 USD | -0.84% | +2.73% | +2.20% | +64.46% | 12.47 B USD | ||
| 822 |  TECH Bio-Techne Corp - Common Stock | 72.47 USD | -0.08% | +0.08% | +0.24% | +19.67% | 11.36 B USD |
Nouvelles Biotechnology Stocks
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
AbCellera présentera des données de phase 1/2 sur son candidat médicament contre la ménopause
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.79 | +16.26% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 28.00 | +11.38% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.54 | +10.60% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 ENLV Enlivex Ltd. - Ordinary Shares | 0.27 | -12.90% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |